• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Phosphorylation of the Antiviral Protein IFITM3 Dually Regulates its Endocytosis and Ubiquitination

tetano

Editor, Senior Moderator
J Biol Chem. 2014 Mar 13. [Epub ahead of print]
Phosphorylation of the Antiviral Protein IFITM3 Dually Regulates its Endocytosis and Ubiquitination.
Chesarino NM1, McMichael TM, Hach JC, Yount JS.
Author information
Abstract

Interferon-inducible transmembrane protein 3 (IFITM3) is essential for innate defense against influenza virus in mice and humans. IFITM3 localizes to endolysosomes where it prevents virus fusion, though mechanisms controlling its trafficking to this cellular compartment are not fully understood. We determined that both mouse and human IFITM3 are phosphorylated by FYN kinase on tyrosine 20 (Tyr-20), and that mouse IFITM3 is also phosphorylated on the non-conserved Tyr-27. Phosphorylation led to a cellular redistribution of IFITM3, including plasma membrane accumulation. Mutation of Tyr-20 caused a similar redistribution of IFITM3 and resulted in decreased antiviral activity against influenza virus, while Tyr-27 mutation of mouse IFITM3 showed minimal effects on localization or activity. Using FYN knockout cells, we also found that IFITM3 phosphorylation is not a requirement for its antiviral activity. Together these results indicated that Tyr-20 is part of an endocytosis signal that can be blocked by phosphorylation or by mutation of this residue. Further mutagenesis narrowed this endocytosis-controlling region to four residues conforming to a YxxΦ endocytic motif, which, when transferred to CD4, resulted in its internalization from the cell surface. Additionally, we found that phosphorylation of IFITM3 by FYN and mutagenesis of Tyr-20 both resulted in decreased IFITM3 ubiquitination. Overall, these results suggest that modification of Tyr-20 may serve in a cellular checkpoint controling IFITM3 trafficking and degradation, and demonstrate the complexity of post-translational regulation of IFITM3.
KEYWORDS:

Endocytosis, IFITM, IFITM3, Influenza virus, Innate immunity, Interferon, Phosphotyrosine, Ubiquitination, phosphorylation, post-translational modification

PMID:
24627473
[PubMed - as supplied by publisher]

Free full text

http://www.ncbi.nlm.nih.gov/pubmed/24627473
 
Back
Top Bottom